Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii

Published:2010-09-22 Issue:12 Volume:65 Page:2598-2601
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:Journal of Antimicrobial Chemotherapy

Author:

Chopra S.,Torres-Ortiz M.,Hokama L.,Madrid P.,Tanga M.,Mortelmans K.,Kodukula K.,Galande A. K.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/65/12/2598/2260349/dkq353.pdf

Reference9 articles.

1. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

2. Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004

3. Antibiotics for Emerging Pathogens

4. Repurposing with a Difference

5. Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of structure of peptidyl-tRNA hydrolase from Enterococcus faecium and its inhibition by a pyrrolinone compound;International Journal of Biological Macromolecules;2024-08

2. Farnesol repurposing for prevention and treatment of Acinetobacter baumannii biofilms;Biofilm;2024-06

3. Optimizing Treatment for Carbapenem-Resistant Acinetobacter baumannii Complex Infections: A Review of Current Evidence;Infection & Chemotherapy;2024

4. Combination of AS101 and Mefloquine Inhibits Carbapenem-Resistant Pseudomonas aeruginosa in vitro and in vivo;Infection and Drug Resistance;2023-11

5. Effects of metformin on Streptococcus suis LuxS/AI-2 quorum sensing system and biofilm formation;Microbial Pathogenesis;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3